Quantitative Systematic Strategies LLC Mersana Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$15.31 - $26.52 $61,515 - $106,557	-4,018 Reduced 23.38%	13,169 $213,000
Q4 2020 Feb 09, 2021	SELL	$16.84 - $27.59 $167,120 - $273,803	-9,924 Reduced 36.61%	17,187 $457,000
Q3 2020 Nov 09, 2020	BUY	$16.2 - $25.7 $106,061 - $168,257	6,547 Added 31.84%	27,111 $505,000
Q2 2020 Aug 04, 2020	SELL	$5.24 - $23.4 $123,281 - $550,531	-23,527 Reduced 53.36%	20,564 $481,000
Q1 2020 May 06, 2020	BUY	$4.41 - $9.28 $100,931 - $212,391	22,887 Added 107.94%	44,091 $257,000
Q4 2019 Feb 11, 2020	BUY	$1.45 - $6.73 $30,745 - $142,702	21,204 New	21,204 $121,000
Q2 2018 Aug 07, 2018	SELL	$14.2 - $22.68 $243,828 - $389,438	-17,171 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$13.56 - $18.48 $232,838 - $317,320	17,171 New	17,171 $271,000

130

104M

58.5K

471K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $56.4M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.